ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
NCT02551185
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
ACY-241
Sponsor
Celgene